Grant: $499,939 - National Institutes of Health - Aug. 14, 2009
0% voted satisfied - 100% voted not satisfied - 1 vote(s) cast
Award Description: This award is for equipment only. The University of Rochester Medical Center (URMC) is sponsoring the construction of a new enhanced Animal Biosafety Level 3 (eABSL3) facility in shell space of the URMC MRBX basement. The facility is being designed to safely accommodate animal experiments with agents such as highly pathogenic avian influenza (HPAI) and other pathogens that require eABSL3 containment. This proposal is a request to fund equipment related to animal care and housing within the new eABSL3 suite. In particular, we are requesting funds for the required biocontainment animal caging, suite decontamination, biosafety cabinets for cage changing and experimental manipulation of animals, and the waste/equipment decontamination systems. All of the equipment requested is for sole use within this suite. All remaining construction and operations costs are NOT a part of this application, and will be supported by the URMC. Upon completion, this facility will operate as a Core to support NIH sponsored research on HPAI and similar pathogens.
Project Description: This award will be used to fund the purchase of capital equipment items needed for the safe operation of a new enhanced animal biosafety level 3 eABSL3 containment facility to be located at the University of Rochester Medical Center. In summary, economic benefits of the award come from: (1) One-time, direct income to the manufacturers from purchasing equipment. (2) Leveraging of the investment by the University for the construction of the facility in undeveloped shell space within the medical center. (3) Ongoing indirect benefits to the federally sponsored research at the University. (1) To preserve and create jobs and promote economic recovery. The eABSL3 suite is an enabling technology that allows university investigators to apply for and compete more effectively for federal research funding of biomedical research on pathogens that require high biocontainment. These benefits apply to both existing research grants that can be more competitive for renewal, and towards new grants and research that would not be possible without the technology. Maintaining existing grants and enabling new grant applications that lead to funding may maintain and create jobs locally. Purchase of the capital equipment items may preserve and create jobs at the manufacturers. (2) To assist those most impacted by the recession. The University and the manufacturers affected by the recession will be directly affected, in particular by offsetting the required investment by the university in the facility. (3) To provide investments needed to increase economic efficiency by spurring technological advances in science and health. The research conducted in the facility, sponsored by the investment of the award in required equipment, will lead to scientific advances and protection of human health from a better understanding of infectious diseases and improved treatments and vaccines. Reduced disease burdens will prevent loss of productivity due to illness.
Jobs Summary: This grant is for equipment only. (Total jobs reported: 0)
Project Status: Not Started
This award's data was last updated on Aug. 14, 2009. Help expand these official descriptions using the wiki below.